New evidence about personality traits and risk of new complications in patients with coronary artery disease. A study by a hypnotic-derived personality classification
Article Sidebar
Main Article Content
Abstract
Five-hundred outpatients with established coronary artery disease underwent to the “analogic personality test” aiming to discriminate the bipolar subpopulation accordingly to the indication of Analogical Disciplines Italian School. Hundred-thirteen bipolar patients (Group 1) were identified and compared to the remaining three hundred-eighty seven patients during a two years clinical follow-up in order to detect possible differences in cardiac death, myocardial infarction, Cerebrovascular Accidents (CVA), re-PCI rate. Significant statistical differences were encountered for each one of the considered events but CVA while ANOVA revealed bipolar personality, diabetes, age, left ventricular ejection fraction <35% and heart failure as significant predictive variables for cardiovascular events. Bipolarism represents a new risk factor for new events in patients with established coronary artery disease.
Downloads
Article Details
Copyright (c) 2020 Roberto B, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Caspi A, Roberts BW, Shiner RL (2005) Personality development: stability and change. Annu Rev Psychol 56: 453-484. Link: https://bit.ly/31PizNj
Ozer DJ, Benet‐Martinez V (2006) Personality and the prediction of consequential outcomes. Annu Rev Psychol 57: 401-421. Link: https://bit.ly/3h9gEK9
Friedman M, Rosenman RH (1960) Overt behavior pattern in coronary disease. Detection of overt behavior pattern A in patients with coronary disease by a new psychophysiological procedure. JAMA 173: 1320-1325. Link: https://bit.ly/3iKIhtn
Friedman M, Rosenman RH (1959) Association of specific overt behavior pattern with blood and cardiovascular findings; blood cholesterol level, blood clotting time, incidence of arcus senilis, and clinical coronary artery disease. JAMA 169: 1286-1296. Link: https://bit.ly/2E1hkCA
Grundy SM, Griffin AC (1959) Effects of periodic mental stress on serum cholesterol levels. Circulation 19: 496-498. Link: https://bit.ly/30U527M
Friedman M, Byers SO, Rosenman RH (1965) Effect of unsaturated fats upon lipemia and conjunctival circulation. A study of coronary-prone (pattern A) men. JAMA 193: 882-886. Link: https://bit.ly/3kLPqLu
Friedman M, St George S, Byers SO, Rosenman RH (1960) Excretion of catecholamines, 17-ketosteroids, 17-hydroxycorticoids and 5-hydroxyindole in men exhibiting a particular behavior pattern (A) associated with high incidence of clinical coronary artery disease. J Clin Invest 39: 758-764. Link: https://bit.ly/2DUaOxJ
Friedman M, Byers SO, Diamant J, Rosenman RH (1975) Plasma catecholamine response of coronary-prone subjects (type A) to a specific challenge. Metabolism 24: 205-210. Link: https://bit.ly/3gYjOA5
Rozanski A, Blumenthal JA, Kaplan J (1999) Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99: 2192-2217. Link: https://bit.ly/3fV9IPk
Suls J, Bunde J (2005) Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. Psychol Bull 131: 260-300. Link: https://bit.ly/31P4DTE
Benemeglio. Benemeglio S. Il potere del gesto. 2005, Ed. CISU, Milano, Italy.
Benemeglio. Il potere del segno. 2005, Ed. CISU, Milano, Italy. Link:
Rosenman RH, Brand RJ, Sholtz RI, Friedman M (1976) Multivariate prediction of coronary heart disease during 8.5 year follow-up in the Western Collaborative Group Study. Am J Cardiol 37: 903-910. Link: https://bit.ly/2CurJGu
Rosenman RH, Friedman M, Straus R, Jenkins CD, Zyzanski SJ, et al. (1970) Coronary heart disease in the Western Collaborative Group Study. A follow-up experience of 4 and one-half years. J Chronic Dis 23: 173-190. Link: https://bit.ly/3kF1fmZ
Rosenman RH, Brand RJ, Jenkins D, Friedman M, Straus R, et al. (1975) Coronary heart disease in Western Collaborative Group Study. Final follow-up experience of 8 1/2 years. JAMA 233: 872-877. Link: https://bit.ly/30SrCOa
Steptoe A (2006) Depression and physical illness. Cambridge: Cambridge University Press. Link: https://bit.ly/33WN9XU
Denollet J (2005) DS14: standard assessment of negative affectivity, social inhibition, and type D personality. Psychosom Med 67: 89-97. Link: https://bit.ly/2POjeJp
Wand Y, Wei D, Li W, Qiu J (2014) Individual differences in brain structure and resting-state functional connectivity associated with type A behavior pattern. 272: 217-228. Link: https://bit.ly/2PQGPZN
Critchley HD, Mathias CJ, Josephs O, Doherty JO, Dolan RJ, et al. (2003) Human cingulate cortex and autonomic control: converging neuroimaging and clinical evidence. Brain 126: 2139-2152. Link: https://bit.ly/3iFENrO
Bertelsen S (1961) Adrenalin-induced alterations in aortic tissue of rabbits compared with changes in human aortic tissue with age. Acta Pathol Microbiol Scand 53: 335-344. Link: https://bit.ly/3gWxmfz
Haft JI (1974) Cardiovascular injury induced by sympathetic catecholamines. Prog Cardiovasc Dis 17: 73-86. Link: https://bit.ly/2E55Cqh
Carruthers ME (1969) Aggression and atheroma. Lancet 2: 1170-1171. Link: https://bit.ly/30W6zu0
Friedman M, Rosenman RH, St George S (1969) Adrenal response to excess corticotropin in coronary-prone men. Proc Soc Exp Biol Med 131: 1305-1307. Link: https://bit.ly/3iC34iw
Grassi G, Seravalle G, Mancia G (2015) Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications. Eur J Clin Invest 45: 1367-1375. Link: https://bit.ly/2CrrFY3
Najafi A, Sequeira V, Kuster DW, van der Velden J (2016) Beta-adrenergic receptor signalling and its functional consequences in the diseased heart. Eur J Clin Invest 46: 362-374. Link: https://bit.ly/3anbKGE
Grassi G, Serravalle G, Quarti-Trevaro F, Dell’Oro R (2009) Sympathetic activation in congestive heart failure: evidence, consequences and therapeutic implications. Curr Vasc Pharmacol 7: 137-145. Link: https://bit.ly/3h7TgfG
Goyal V, Jassal DS, Dhalla NS (2016) Pathophysiology and prevention of sudden cardiac death. Can J Physiol Pharmacol 94: 237-244. Link: https://bit.ly/3apW5qg
Esler M, Kaye D (2000) Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol 7: S1-S7. Link: https://bit.ly/2XZKCIQ
Remme WJ (1998) The sympathetic nervous system and ischaemic heart disease. Eur Heart J 19: F62-F71. Link: https://bit.ly/3fXdh7A
Friedman M, Byers SO, Rosenman RH (1972) Plasma ACTH and cortisol concentration of coronary-prone subjects. Proc Soc Exp Biol Med 140: 681-684. Link: https://bit.ly/2DHvPf5
Friedman M, Byers SO, Roseman RH, Elevitch FR (1970) Coronary-prone individuals (type A behavior pattern). Some biochemical characteristics. JAMA 212: 1030-1037. Link: https://bit.ly/2PTstYC
Friedman M, Byers SO, Rosenman RH, Neuman R (1971) Coronary-prone individuals (type A behavior pattern). Growth hormone responses. JAMA 217: 929-932. Link: https://bit.ly/3iD3NQA
Friedman M, Byers SO, Elek SR (1969) The induction of neurogenic hypercholesteremia. Proc Soc Exp Biol Med 131: 759-762. Link: https://bit.ly/30UW6iE
Friedman M, Byers SO, Elek S (1972) Neurogenic hypercholesterolemia. II. Relationship to endocrine function. Am J Physiol 223: 473-479. Link: https://bit.ly/2PPDeeq
Byers SO, Friedman M (1973) Neurogenic hypercholesterolemia. 3. Cholesterol synthesis, absorption, and clearance. Am J Physiol 225: 1322-1326. Link: https://bit.ly/3gUBKvq
Friedman M, Byers SO, Elek S (1973) The pathogenesis of neurogenic hypercholesterolemia. IV. Abnormal metabolism of chylomicronous cholesterol. Proc Soc Exp Biol Med 142: 359–364. Link: https://bit.ly/3iRydyP
Byers SO, Friedman M, Neuman R (1974) Neurogenic hypercholesterolemia: influence upon lipoproteins. Proc Soc Exp Biol Med 145: 442–445. Link: https://bit.ly/3kL6VvJ